The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Although platelets are widely recognized as having a critical role in primary hemostasis and
thrombosis, increasing experimental and clinical evidence identifies these enucleated cells …

The use of blood derivatives represents an alternative therapeutic approach that is gaining
interest in regenerative medicine due to its potential to stimulate and accelerate tissue …

The use of blood derived eye drops for the treatment of ocular surface disorders has become
increasingly popular in recent years. The mechanism of action is the stimulation of cellular …

Ocular graft-versus-host disease (oGVHD) occurs as a complication following hematopoietic
stem cell transplantation and is associated with significant ocular morbidity resulting in a …

The poor healing potential of tendons is still a clinical problem, and the use of Platelet Rich
Plasma (PRP) was hypothesized to stimulate healing. As the efficacy of PRPs remains …

Objective To evaluate and compare the symptomatology and clinical findings in
hyposecretory dry eye of the treatment with platelet‐rich plasma (PRP) and artificial tears of …

Hemoderivative materials are used to treat different diseases. These derivatives include
platelet‐rich plasma, serum, platelet gel, and platelet lysate (PL). Among them, PL contains …

The use of blood-based eye drops as therapy for various diseases of the ocular surface has
become increasingly popular in ophthalmic practice during recent years. The rationale for …

Ocular graft versus host disease (oGVHD) is part of a systemic inflammatory disease that
usually affects ocular surface tissues manifesting as a dry eye syndrome. Current treatments …